REGN5678 Clinical Trials
4 recruitingDrug
Phase 14Phase 23
Showing 1–4 of 4 trials
Recruiting
Phase 1
A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC
Prostate Cancer
M.D. Anderson Cancer Center60 enrolled1 locationNCT06826768
Recruiting
Phase 1Phase 2
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With Cemiplimab or REGN5678 for Adult Participants With Advanced Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Regeneron Pharmaceuticals370 enrolled14 locationsNCT05125016
Recruiting
Phase 1Phase 2
A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy
Prostate CancerRadical Prostatectomy
M.D. Anderson Cancer Center42 enrolled1 locationNCT06085664
Recruiting
Phase 1Phase 2
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
Regeneron Pharmaceuticals345 enrolled21 locationsNCT03972657